Decoy Therapeutics DCOY
NASDAQ DCOY
$1.08 -0.06 (-5.29%)
As of: Oct 21, 2026 · 3:55 PM EDT

Decoy Therapeutics (DCOY) Capital Expenditures (2015 - 2017)

Updated

Decoy Therapeutics (DCOY) recorded Capital Expenditures of $577,000 in FY2025.

Analysis

Decoy Therapeutics (DCOY) Capital Expenditures (2015 - 2017) Analysis & Trends

Starting with FY2014, Decoy Therapeutics' Capital Expenditures history includes 6 years.

  • Annual Capital Expenditures has a five-year compound annual growth rate of 194.6% (FY2020 to FY2025).
  • The FY2025 figure is the highest annual Capital Expenditures in data going back to FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Decoy Therapeutics 571,865.63 -31.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 15,398.00
Sep 30, 2017 44,359.00
Jun 30, 2017 31,591.00
Mar 31, 2017 22,150.00
Dec 31, 2016 50,391.00
Sep 30, 2016 218,785.00
Jun 30, 2016 182,916.00
Mar 31, 2016 107,286.00
Dec 31, 2015 42,352.00
Sep 30, 2015 147,703.00
Jun 30, 2015 49,167.00
Mar 31, 2015 26,395.00
API Access

Decoy Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DCOY&period=max&api_key=YOUR_API_KEY